Here, they show that Very-long-chain 1-deoxyceramides impair mitochondrial function and cause toxicity. Inhibiting ELOVL1 prevents these effects, suggesting a therapeutic strategy for disorders linked to elevated 1-deoxysphingolipid levels.
- Adam Majcher
- Gergely Karsai
- Thorsten Hornemann
